Abstract
Introduction
The aim of the present study was to assess if the presence of survivin mRNA in exfoliated cells present in urine samples can be a reliable marker of the presence of bladder tumour and recurrence.
Materials and methods
Urine samples from 30 patients with superficial urothelial cell carcinomas (UCC) were collected prior to transurethral resection (TUR) of the tumour and in the first routine follow-up, three months after TUR. Detection of survivin mRNA was performed by reverse transcription-polymerase chain reaction (RT-PCR).
Results
No correlation was observed between survivin detection and the clinico-pathological variables analysed, nevertheless, when patients were grouped into low-grade (G1) and high-grade (G2+G3) tumours, statistically significant differences were found between both groups (p=0.04). When we analysed the results of survivin detection and urinary cytology together, we observed that informative cases rose from 27.8% to 44.4%. Also, Kaplan-Meier curves for patients with negative cytology in the first follow-up, categorised according to survivin detection, revealed that survivin mRNA positive cases recurred earlier than negative ones.
Conclusions
From our results we can conclude that detection of survivin expression can be a reliable tumour marker, but more studies are needed to clarify the potential of survivin to predict recurrences. These results showed that survivin detection in combination with conventional urinary cytology can be a useful tool to increase the sensitivity in detecting the presence of a recurrence after TUR.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baithun S, Daruwala P, Oliver RT (1998) Squamous changes in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer. Cancer Surv 31: 17–27
Yudong W, Wang G, Wei J, Wen X (2005) Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer. Indian J Med Sci 59:235–242
Sharp JD, Hausladen DA, Maher MG et al (2002) Bladder cancer detection with urinary survivin, an inhibitor of apoptosis. Frontiers Biosci 7:e36–41
Wiener HG, Vooijs GP, Hof-Grootenboer BV (1993) Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37:163–169
Ramakumar S, Bhuiyan J, Besse JA (1999) Comparison of screening methods in the detection of bladder cancer. J Urol 161:388–394
Weikert S, Christoph F, Schrader M et al (2005) Quantitative analysis of survivin mRNA expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116:100–104
Ku J, Kwak C, Lee H et al (2004) Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171:631–635
Schultz IJ, Kiemeney LA, Witjes JA et al (2003) Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23:3327–3331
Shariat SF, Casella R, Khoddami SM et al (2004) Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171:626–630
Smith SD, Wheeler MA, Plescia J et al (2001) Urine detection of survivin and diagnosis of bladder cancer. JAMA 285:324–328
Swana HS, Grossman D, Anthony JN et al (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452–453
Wang H, Xi X, Kong X, Ge GHG (2004) The expression and significance of survivin mRNA in urinary bladder carcinomas. J Cancer Res Clin Oncol 130:487–490
Schultz IJ, Kiemeney LA, Karthaus HFM et al (2004) Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Clin Chem 50:1425–1428
Hausladen DA, Wheeler MA, Altieri DC et al (2003) Effect of intravesical treatment of transitional cell carcinoma with bacillus calmetteguerin and mitomycin C on urinary survivin levels and outcome. J Urol 170:230–234
Mostofi FK, Sorbin LH, Torloni H (1973) Histological typing of urinary bladder tumours. International histological classification of tumours, 19. Geneva: World Health Organization
American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th Edn. New York: Lippincott-Raven
Gazzaniga P, Gradilone A, Giuliani L et al (2003) Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14:85–90
Hoffman WH, Biade S, Zilfou JT et al (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247–3257
Spruck CH, Ohneseit PF, Gonzalez-Zulueta M et al (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784–788
Santos L, Amaro T, Costa C et al (2003) KI-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 105:267–272
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pina-Cabral, L., Santos, L., Mesquita, B. et al. Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas. Clin Transl Oncol 9, 731–736 (2007). https://doi.org/10.1007/s12094-007-0130-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-007-0130-4